NEW ARTICLE: Ivermectin and Fenbendazole: A Testimonial of Hope for Stage 4 Prostate Cancer Patients! From PSA 1533 to 968 in 12 Days
Ready to uncover the truth? Sick of the lies? Join our Telegram Channel now. It’s time for the real story! My gratitude to all my readers!
Explore the dramatic recovery of a Stage 4 prostate cancer patient: PSA plummets 37% in 12 days with Ivermectin and Fenbendazole. Learn about this innovative treatment, its life-changing potential, and why it’s reshaping cancer care.
From PSA 1533 to 968 in 12 Days: A Story of Dramatic Recovery
Imagine being handed a diagnosis that feels like a death sentence: Stage 4 prostate cancer, with a Prostate-Specific Antigen (PSA) level of 1533, a grim indicator of aggressive cancer spread. Now, picture the miraculous transformation when this PSA level plummets to 968—a staggering 37% drop—in just 12 days.
This is not just a story. This is reality for one man who embraced an unconventional yet powerful treatment protocol combining Ivermectin and Fenbendazole. In this article, we dive deep into this breakthrough, unravel the science behind it, and explore why these drugs could redefine cancer treatment.
NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial – Stage 4 Prostate Cancer patient – PSA drops 1533 to 968 in 12 days – is fatigue and bone pain normal?
Stage 4 Prostate Cancer patient:
Started Ivermectin 1mg/kg and Fenbendazole 1000mg 3 days on 4 days off.
In 12 days PSA… pic.twitter.com/vhKzfoNogC
— William Makis MD (@MakisMD) November 19, 2024
The New Hope for Advanced Cancer
It’s not every day you hear about cancer patients seeing results this dramatic, this quickly. Yet, here we are, talking about a man who started a unique treatment plan involving Ivermectin at 1mg/kg and Fenbendazole at 1000mg (on a “three days on, four days off” schedule). This approach not only reduced his PSA levels significantly in less than two weeks but also led to the disappearance of abdominal cancer lymph nodes.
Are we witnessing the dawn of a revolution in cancer therapy? Let’s break it down.
The Dramatic PSA Drop: What Does It Mean?
The PSA (Prostate-Specific Antigen) level serves as a biomarker for prostate cancer progression. A reading of 1533 is almost unheard of and indicates advanced, metastatic disease. For this patient, dropping to 968 in only 12 days signals that something extraordinary is happening.
Why is this important?
- A 37% reduction in PSA over such a short period suggests rapid destruction of cancer cells.
- This decline also correlates with the visible disappearance of abdominal cancer lymph nodes.
Such a transformation often takes months with standard therapies like chemotherapy or radiation. This testimonial challenges conventional timelines, suggesting these repurposed drugs hold untapped potential.
Why Ivermectin and Fenbendazole?
Ivermectin has long been celebrated as an antiparasitic drug, while Fenbendazole is primarily used in veterinary medicine to deworm animals. So, why are these medications being linked to cancer treatment?
- Ivermectin’s Role in Cancer Treatment
Research has increasingly shown Ivermectin’s ability to:-
Inhibit cancer cell proliferation.
-
Interfere with tumor growth by targeting specific signaling pathways.
-
Reduce inflammation and enhance immune system responses.
Essentially, Ivermectin appears to disrupt the “communication lines” cancer cells use to grow and spread.
-
- Fenbendazole’s Unexpected Cancer-Fighting Properties
Fenbendazole, on the other hand, works by targeting cancer cells’ microtubules—essential structures that enable cell division. By interfering with microtubule function, Fenbendazole hampers cancer cells’ ability to multiply.
Together, these two drugs attack cancer from different angles, creating a synergistic effect that amplifies their individual strengths.
MAKE AMERICA HEALTHY AGAIN: HOME RETREAT | HOW TO RENEW YOUR CELLS IN 7 DAYS
Understanding Fatigue and Bone Pain During Treatment
Cancer treatment is not a walk in the park. For this patient, the combination of Ivermectin and Fenbendazole led to rapid cancer cell death—a process often called tumor lysis syndrome.
Fatigue: The Aftermath of a Cellular Battlefield
When cancer cells die, they release toxins into the body. The immune system must work overtime to clear these toxins, leaving patients feeling drained. This fatigue is a sign that the body is actively fighting the disease.
Bone Pain: A Sign of Healing?
As cancer cells embedded in bone are destroyed, inflammation can occur, leading to temporary bone pain. While uncomfortable, this is often a precursor to healing. Over time, the body repairs the damage, and the pain subsides.
Both fatigue and bone pain are normal responses to the intense cellular changes happening within the body.
The Bigger Picture: What This Means for Cancer Patients
This testimonial isn’t just about one man’s journey; it’s a beacon of hope for thousands of others battling late-stage cancer. The success of this treatment raises several critical questions:
- Could repurposed drugs like Ivermectin and Fenbendazole offer a low-cost, accessible alternative to traditional cancer therapies?
- Why isn’t this being studied more aggressively by mainstream medicine?
- How can we make these treatments available to more patients?
These questions demand answers, especially when lives hang in the balance.
The Elephant in the Room: Access and Awareness
The harsh reality is that Ivermectin and Fenbendazole are not readily available for cancer patients in many parts of the world. Despite mounting evidence of their efficacy, regulatory hurdles and misinformation campaigns have made it challenging to access these drugs.
India: A Lifeline for Ivermectin
Currently, India remains one of the few places where Ivermectin is accessible without exorbitant costs or prescription barriers. However, many patients are hesitant to source medications internationally, fearing scams or quality issues.
A Call to Action
It’s time for policymakers to step up. Making Ivermectin an over-the-counter medication could save countless lives.
The Role of the Immune System in This Protocol
One of the reasons this treatment is so effective is its ability to bolster the immune system. Both Ivermectin and Fenbendazole work indirectly to enhance immune surveillance, making it harder for cancer cells to “hide” from the body’s natural defenses.
Key Immune Benefits:
- Reduced inflammation.
- Enhanced recognition of cancer cells by immune cells.
- Improved overall immune resilience.
For a Stage 4 cancer patient, this immune boost can be the difference between life and death.
Overcoming the Stigma Around Alternative Treatments
Critics often dismiss unconventional cancer treatments as “unscientific” or “dangerous.” Yet, this testimonial stands as evidence that we cannot afford to ignore the potential of repurposed drugs.
Why the Skepticism?
- Big Pharma has little financial incentive to promote low-cost drugs like Ivermectin.
- Conventional medicine often prioritizes treatments with long-established protocols, even when newer, more effective options exist.
It’s time to put patients first and explore every avenue for curing this devastating disease.
Hope for the Future: Could Ivermectin Become Mainstream?
Imagine a future where Ivermectin and Fenbendazole are part of every oncologist’s toolkit—a world where late-stage cancer no longer feels like an automatic death sentence.
Steps to Make This Happen:
- Increase funding for research on repurposed drugs.
- Educate medical professionals about alternative therapies.
- Advocate for regulatory changes that make these treatments more accessible.
Every step we take brings us closer to that reality.
Crime of the Century: Big Pharma Doesn’t Want You to Know About Alternative: How to Make Natural Morphine At Home Using This Powerful Medicinal Plant
The Final Word: A Journey Worth Celebrating
This Stage 4 prostate cancer patient’s journey is a testament to the power of persistence, innovation, and hope. His PSA drop from 1533 to 968 is not just a number; it’s a symbol of life reclaimed, of a future reimagined.
While the fight against cancer is far from over, stories like this remind us that breakthroughs are possible. Ivermectin and Fenbendazole may not yet be mainstream, but their potential is undeniable.
Let this story serve as both inspiration and a call to action. The time to explore unconventional cancer treatments is now. The lives we save tomorrow depend on the steps we take today.
SOURCE: https://x.com/MakisMD/status/1858828115708961008?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%
